Vaginal metabolome: towards a minimally invasive diagnosis of microbial invasion of the amniotic cavity in women with preterm labor

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Vicente-Munoz, S
  • Cobo, T
  • Sanchez-Garcia, AB
  • Agust, N
  • Palacio, M
  • Gratacos, E

Grupos

Abstract

Microbial invasion of the amniotic cavity (MIAC) is only identified by amniocentesis, an invasive procedure that limits its clinical translation. Here, we aimed to evaluate whether the vaginal metabolome discriminates the presence/absence of MIAC in women with preterm labor (PTL) and intact membranes. We conducted a case-control study in women with symptoms of PTL below 34 weeks who underwent amniocentesis to discard MIAC. MIAC was defined as amniotic fluid positive for microorganisms identified by specific culture media. The cohort included 16 women with MIAC and 16 control (no MIAC). Both groups were matched for age and gestational age at admission. Vaginal fluid samples were collected shortly after amniocentesis. Metabolic profiles were analyzed by nuclear magnetic resonance (NMR) spectroscopy and compared using multivariate and univariate statistical analyses to identify significant differences between the two groups. The vaginal metabolomics profile of MIAC showed higher concentrations of hypoxanthine, proline, choline and acetylcholine and decreased concentrations of phenylalanine, glutamine, isoleucine, leucine and glycerophosphocholine. In conclusion, metabolic changes in the NMR-based vaginal metabolic profile are able to discriminate the presence/absence of MIAC in women with PTL and intact membranes. These metabolic changes might be indicative of enhanced glycolysis triggered by hypoxia conditions as a consequence of bacterial infection, thus explaining the utilization of alternative energy sources in an attempt to replenish glucose.

Datos de la publicación

ISSN/ISSNe:
2045-2322, 2045-2322

SCIENTIFIC REPORTS  NATURE PUBLISHING GROUP

Tipo:
Article
Páginas:
5465-5465
PubMed:
32214212
Factor de Impacto:
1,240 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 5

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • PRENATAL DISORDERS; FLUID; SPECTROSCOPY; PREGNANCY; CHOLINE; PROFILE; MARKER; IMPACT; BIRTH

Campos de Estudio

Proyectos y Estudios Clínicos

UNA APROXIMACIÓN ÓMICA AL DIAGNÓSTICO DE LA TUBERCULOSIS

PCIN-2013-041 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015

HERRAMIENTAS DE RMN PARA EL DESARROLLO DE UNA PLATAFORMA PARA LA IDENTIFICACIÓN DE DIANAS, LA EVALUACIÓN DE FÁRMACOS Y LA PERSONALIZACIÓN DE TRATAMIENTOS BASADA EN APROXIMACIONES METABOLÓMICAS

Investigador Principal: ANTONIO PINEDA LUCENA

SAF2014-53977-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2015

RECALL. DESARROLLO DE PROTOTIPOS QUÍMICOS ORIENTADOS A LA GENERACIÓN DE TERAPIAS AVANZADAS PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER

Investigador Principal: ANTONIO PINEDA LUCENA

RTC-2016-4803-1 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016

Plataforma de Innovación en Tecnologías Médicas y Sanitarias - ITEMAS

Investigador Principal: SILVIA SÁNCHEZ SALVO

PT17/0005/0011 . INSTITUTO DE SALUD CARLOS III . 2018

Identificación de biotipos moleculares de cáncer de próstata como base de una medicina de precisón (BIOChiP).

Investigador Principal: LÓPEZ

PROMETEO/2016/103 . 2016

Estudio del papel de la heparanasa en la resistencia a los tratamientos para el mieloma múltiple.

GV/2017/ . 2018

NUEVOS PROCEDIMIENTOS PARA EVALUAR LA INTERACCIÓN ENTRE VACUNAS ANTINEUMOCÓCICAS E IGGS GENERADAS EN PACIENTES VACUNADOS.

Investigador Principal: ANTONIO PINEDA LUCENA

APL-VAC-2018-01 . 2019

Cita

Compartir